What Is Ekbom Syndrome? Causes, Diagnosis, and Management

Ekbom syndrome most commonly refers to delusional parasitosis, a psychiatric condition in which a person holds an unshakeable belief that their skin is infested with parasites, insects, or other organisms despite no medical evidence of any infestation. The term is sometimes confused with Willis-Ekbom disease, which is the modern name for restless legs syndrome, an entirely separate movement disorder. Both conditions were described by the Swedish neurologist Karl-Axel Ekbom, which is why the naming overlap persists. Understanding which condition is being discussed matters because their causes, symptoms, and treatments have almost nothing in common.

Delusional Parasitosis and What It Feels Like

People with delusional parasitosis experience persistent, false beliefs that they are infested by parasites or other organisms, accompanied by symptoms like formication (a crawling or tingling sensation on or under the skin), itching, and self-inflicted skin damage from scratching, picking, or using caustic substances to “remove” the perceived invaders.1PubMed Central. Can You Properly Manage Delusional Parasitosis? The conviction is fixed and firm. Patients do not waver when told that lab tests, skin biopsies, and dermatological exams have all come back negative.2PubMed Central. The Diagnostic Workup, Screening, and Treatment Approaches for Patients with Delusional Infestation This unshakeable quality is what distinguishes it from ordinary health anxiety: the person is not worried they might have an infestation but absolutely certain they do.

One of the most recognizable behaviors is what clinicians call the “specimen sign.” Patients collect what they believe to be evidence of their infestation, pieces of skin, lint, scabs, or other debris, and bring them to appointments in matchboxes, plastic bags, or tape strips. A European study of 148 consecutive cases found that this behavior is typical but not universal, and the researchers suggested the term “specimen sign” as a more accurate label than the older “matchbox sign.”3PubMed. Delusional infestation and the specimen sign: a European multicentre study in 148 consecutive cases When a dermatologist or primary care doctor sees a patient arrive with collected specimens and extensive self-inflicted skin lesions but no evidence of actual parasites, delusional parasitosis moves high on the list of possibilities.

The personal toll goes beyond skin damage. Some patients undergo repeated antiparasitic treatments, discard furniture and possessions, abandon pets, or even destroy parts of their homes in attempts to eliminate the perceived infestation, none of which brings relief.4CosmoDerma. Delusional infestation: An update The condition can consume a person’s daily life and relationships, and the frustration of not being believed by doctors only deepens the distress.

Primary Versus Secondary Forms

Delusional parasitosis is classified as either primary or secondary. In the primary form, the delusion arises on its own without another medical or psychiatric condition driving it. In the secondary form, the delusion develops as a consequence of something else: a neurological disease, a metabolic disorder, or substance use. The distinction matters because treating the underlying cause can resolve secondary cases in ways that would not work for primary ones.

Conditions linked to secondary delusional parasitosis include strokes affecting the non-dominant hemisphere, dementia, severe kidney disease, vitamin B12 deficiency, and even pellagra. Structural brain abnormalities such as subcortical vascular disease and right-hemisphere damage in the temporo-parietal region have been reported.5Egyptian Journal of Dermatology and Venerology. Ekbom’s Delusional Parasitosis: A Systematic Review In younger adults, recreational drug use is an important consideration. Cocaine is well known for triggering formication, sometimes called “cocaine bugs,” which produces crawling sensations often accompanied by hallucinations and ideas of contamination.6European Psychiatry. Ekbom Syndrome in the context of psychotic depression and cocaine use: A case report Beyond recreational substances, certain prescription medications that alter dopamine, norepinephrine, or serotonin levels can trigger tactile hallucinations resembling the condition.7PubMed. Drug-Induced Tactile Hallucinations Beyond Recreational Drugs

What Happens in the Brain

The neuroscience behind delusional parasitosis points to dopamine. MRI studies have found abnormalities in the striatum, particularly the putamen, a brain region involved in processing bodily sensations. Disrupted functioning in the striato-thalamo-cortical loop, the circuit that links deeper brain structures to the cortex for processing somatic information, appears to play a significant role. The fact that drugs known to affect the dopamine transporter (cocaine, methylphenidate, bupropion) can trigger the condition adds further support to the dopamine hypothesis.8PubMed. Striatal lesions in delusional parasitosis revealed by magnetic resonance imaging

PET imaging has provided more direct evidence. In one study, a patient with untreated delusional parasitosis showed reduced dopamine turnover in presynaptic neurons of both the caudate and putamen compared to healthy controls.9Progress in Neuro-Psychopharmacology and Biological Psychiatry. Delusional infestation: Neural correlates and antipsychotic therapy investigated by multimodal neuroimaging This fits neatly with the clinical observation that antipsychotic medications, which work by blocking dopamine receptors, tend to be the most effective treatment.

Conditions like multiple sclerosis can create a bridge between real neurological sensations and delusional thinking. In a reported case, a patient with longstanding MS developed persistent generalized itching that repeatedly yielded negative dermatological results, eventually progressing into a fixed false belief of parasitic infestation.10PubMed Central. Neuropathic Pruritus as a Precursor to Delusional Parasitosis in Multiple Sclerosis: A Proposed Clinical Trajectory and Case Report The case illustrates how genuine nerve-driven itching can, in some patients, serve as a stepping stone toward full delusional conviction.

When the Delusion Spreads to Others

One of the more striking features of delusional parasitosis is that the belief can spread to close contacts. When a second person adopts the delusion, the phenomenon is called folie à deux; when a third person picks it up, it becomes folie à trois. This shared psychotic pattern tends to develop in close relationships where one person (the “primary” case) holds the delusion firmly, and a partner, child, or other household member gradually comes to share it.11PubMed Central. Delusional parasitosis with folie à deux: A case series The shared belief persists even when evidence clearly contradicts it.12PubMed Central. Shared Delusional Parasitosis in Two Families: Clinical Insights Into Folie à Deux and Folie à Trois

This is not a trivial curiosity. It means clinicians need to assess not just the patient sitting in front of them but also the household environment. If a family member shares the belief, simply treating one person may not be enough, and the secondary case may reinforce the primary patient’s conviction during and after treatment.

Diagnosis Without a Definitive Test

There is no blood test or brain scan that confirms delusional parasitosis. Diagnosis happens by exclusion: the clinician must first rule out every plausible cause of skin symptoms, including scabies, lice, dermatitis, fungal infections, and neuropathies, before concluding that the infestation belief is delusional. That workup typically includes dermatological examination, skin scraping, biopsy when warranted, and sometimes blood work to check for conditions like thyroid disease, B12 deficiency, kidney dysfunction, or substance use.2PubMed Central. The Diagnostic Workup, Screening, and Treatment Approaches for Patients with Delusional Infestation

The challenge is that patients rarely show up at a psychiatrist’s office. They present to dermatologists, entomologists, pest control professionals, and primary care doctors, convinced they have a physical problem. The mismatch between the patient’s certainty and the clinician’s findings is itself a diagnostic signal, but it also creates friction. A patient who has seen four dermatologists and been told each time that nothing is wrong does not view the fifth doctor’s identical conclusion as reassuring. They view it as another failure.

Management and the Therapeutic Relationship

Antipsychotic medications are the mainstay of pharmacological treatment. The evidence base, while limited to retrospective studies and case series rather than large randomized trials, consistently shows that these drugs reduce the severity of symptoms. A retrospective cohort study found that all six antipsychotics tested significantly reduced symptom severity over six months. Amisulpride, paliperidone, and risperidone produced the most substantial improvements, while pimozide showed reasonable results and aripiprazole and olanzapine were less effective.13PubMed. Efficacy of Antipsychotic Treatment for Delusional Infestation: A Retrospective Cohort Study A systematic review of older literature found that risperidone achieved full or partial remission in all six patients for whom it was prescribed, at doses ranging from 1 to 8 mg per day.14The British Journal of Psychiatry. Antipsychotic treatment of primary delusional parasitosis: Systematic review

When patients stick with treatment for more than about two months, outcomes improve substantially. A case-based analysis found that if therapy lasted longer than eight weeks, every case responded at least partially. Across all patients in that study, roughly three-quarters achieved partial or full remission. Secondary delusional parasitosis responded somewhat better than primary cases. Doses used tended to be lower than those prescribed for schizophrenia.15Journal of Clinical Psychopharmacology. Second-Generation Antipsychotics in Primary and Secondary Delusional Parasitosis

The harder part is getting patients to accept medication in the first place. Because patients are convinced they have a physical problem, not a psychiatric one, they are characteristically reluctant to pursue psychiatric evaluation and resist framing their condition in psychiatric terms.16PubMed. Current Understanding and Approach to Delusional Infestation Building therapeutic rapport is arguably more important than choosing the right drug. Practical guides have been developed that suggest specific language dermatologists can use to introduce antipsychotic treatment without triggering the patient’s defenses, such as framing the medication as something that addresses nerve signals or skin sensitivity rather than leading with a psychiatric diagnosis.17PubMed. Delusions of parasitosis; suggested dialogue between dermatologist and patient

Ethical Tensions in Treatment

That careful framing raises a genuine ethical question. If a doctor describes an antipsychotic as a “nerve medication” to make it more acceptable, is that therapeutic pragmatism or is it withholding information from the patient? The medical ethics literature on this has pushed back against the use of “therapeutic privilege,” the practice of deliberately limiting what the patient is told. The argument is straightforward: even when telling a patient the full truth risks them refusing treatment, the physician still has an obligation to respect their autonomy, provide complete information, and obtain informed consent before making a psychiatric referral.18PubMed. Information, consent and treatment of patients with Morgellons disease: an ethical perspective In practice, many clinicians walk a line between honesty and tact, acknowledging the patient’s distress as real while being transparent about what the medication is and how it works.

Willis-Ekbom Disease, the Other Ekbom Syndrome

The naming confusion is worth untangling because it comes up constantly. Willis-Ekbom disease (WED) is the formal name for restless legs syndrome (RLS), a common movement disorder characterized by an uncomfortable urge to move the legs, typically worse at rest and in the evening, with relief when you get up and walk around.19Clinical Medicine. Restless legs syndrome It has nothing to do with delusions or parasites. The overlap in naming exists solely because Ekbom published landmark descriptions of both conditions in the mid-twentieth century.

RLS severity is assessed by how much it disrupts daily life under different circumstances: while falling asleep, during the night, during the day while sitting, and during the day while moving.20PubMed. Rating of daytime and nighttime symptoms in RLS: validation of the RLS-6 scale of restless legs syndrome/Willis-Ekbom disease People with more severe forms may get only four to five hours of sleep per night, with cascading effects on mood, cognition, and fatigue.21European Neurological Review. The Impact of Restless Legs Syndrome/ Willis–Ekbom Disorder on Quality of Life

How Restless Legs Syndrome Works

Two factors drive RLS at the brain level: iron deficiency in the brain and a resulting disruption of the dopamine system. Research using cerebrospinal fluid analysis, autopsy material, and brain imaging consistently shows reduced iron in certain brain regions in RLS patients.22PubMed. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease) The current understanding is that insufficient brain iron disrupts dopamine signaling, which then produces the sensorimotor symptoms.23PubMed Central. Brain-iron deficiency models of restless legs syndrome That iron deficiency acts primarily through its effects on dopamine is supported by the fact that both iron supplementation and dopamine-targeting drugs provide symptom relief, though for somewhat different patient subsets.24PubMed. The role of iron in restless legs syndrome

There is also a strong genetic component. Genome-wide association studies have identified several risk variants, with some of the strongest associations found in a gene called MEIS1, among the most robust genetic links reported for any common disease.25PubMed Central. MEIS1 and Restless Legs Syndrome: A Comprehensive Review Other genes implicated include BTBD9, TOX3, MAP2K5/SKOR1, and PTPRD, all of which have been linked to increased periodic leg movements during sleep as well.26Sleep. Periodic Leg Movements during Sleep Are Associated with Polymorphisms in BTBD9, TOX3/BC034767, MEIS1, MAP2K5/SKOR1, and PTPRD If RLS runs in your family, this is why.

Treating Restless Legs Syndrome and the Augmentation Problem

First-line drug treatment for moderate to severe RLS typically involves dopamine agonists such as pramipexole, ropinirole, or rotigotine, all of which have consistently outperformed placebo in clinical trials.27PubMed. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome Gabapentin enacarbil, a prodrug of gabapentin, is an alternative that works through a different mechanism, binding to calcium channels rather than dopamine receptors.28PubMed Central. Review of the Treatment of Restless Legs Syndrome: Focus on Gabapentin Enacarbil

The major long-term complication of dopamine-based treatment is augmentation: a paradoxical worsening of RLS symptoms during ongoing therapy, where symptoms start earlier in the day, spread to the arms, or become more intense despite stable or increased doses. Early reports found augmentation in as many as 73% of patients treated with levodopa.29PubMed. Dopaminergic augmentation of restless legs syndrome More recent community data puts the rate at roughly 8% per year for at least the first eight years of treatment, with about 20% of patients overall showing definitive or strongly suggestive signs. Risk factors include more frequent and more uncomfortable symptoms before starting treatment and longer treatment duration.30PubMed. Restless legs syndrome augmentation associated with dopamine agonist and levodopa usage in a community sample Why augmentation happens remains an open question.31PubMed Central. Exploring the causes of augmentation in restless legs syndrome This risk is a major reason clinicians have increasingly favored gabapentin-based treatments or iron supplementation as first steps, particularly for milder cases.

Beyond medication, a systematic review of randomized controlled trials found that exercise, compression devices, repetitive transcranial magnetic stimulation, infrared therapy, and acupuncture were all more effective than control conditions for reducing RLS severity. Vibration pads, cryotherapy, and transcranial direct current stimulation were not.32PubMed. Non-pharmacological interventions for restless legs syndrome: a systematic review of randomised controlled trials For people with mild symptoms or those hoping to delay medication, regular exercise and compression stockings are among the lowest-risk options worth trying.

Challenges Across the Lifespan

Both conditions present differently at the extremes of age. RLS diagnosis can be especially tricky in children, who may not describe the leg sensations in the standard way, sometimes using language that sounds more like growing pains or restlessness at bedtime. In older adults, overlapping conditions like peripheral neuropathy or medication side effects can mask or mimic RLS, making it hard to disentangle.33PubMed Central. Restless Legs Syndrome across the Lifespan: Symptoms, Pathophysiology, Management and Daily Life Impact of the Different Patterns of Disease Presentation Long-term medication management becomes more complicated in elderly patients as well, both because of augmentation risk with dopamine agonists and because of the cumulative burden of polypharmacy.

Delusional parasitosis, meanwhile, occurs most commonly in middle-aged to older women, though it can affect anyone. Elderly patients living alone may be especially vulnerable because social isolation limits the reality checks that come from daily interaction with others. When the condition goes unrecognized, patients sometimes cycle through dermatologist after dermatologist, pest control service after pest control service, accumulating bills and frustration without ever receiving psychiatric evaluation.

Quality of Life and the Burden of Living With Either Condition

RLS has a documented impact on quality of life that goes well beyond inconvenience. Patients with more severe forms report deficits of 10 to 40 points on standard 100-point quality-of-life scales across physical functioning, pain, mental health, and vitality compared with the general population.34PubMed. Evaluating the quality of life of patients with restless legs syndrome In patients on maintenance dialysis, RLS was an independent predictor of worse quality of life even after adjusting for sleep quality, meaning its impact went beyond just ruining sleep.35PubMed. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis

Delusional parasitosis imposes a different kind of burden, more social and psychological. The condition strains relationships with family members and healthcare providers, often leads to expensive and unnecessary home treatments, and can result in serious skin infections from self-inflicted wounds. For the person experiencing it, the suffering is entirely real: they feel the sensations, they see what they believe is evidence, and they cannot understand why no one else takes it seriously. When treatment works, the relief is profound, but the path to getting there demands patience and skill from everyone involved.